Docetaxel Injection, Solution
Product Images NDC 43598-259

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Docetaxel (NDC 43598-259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4carton (4carton)

FDA Label Image

4vial (4vial)

Not available.*

FDA Label Image

8carton

This is a description of Docetaxel Injection, USP, a chemotherapy drug that comes in a single-use vial of 8 mL containing 160mg of the drug at a concentration of 20mg/mL. The drug is intended for intravenous infusion only and should be protected from light and stored at temperatures between 36-77°F. The one-vial formulation contains 20mg of docetaxel and 3mg of citric acid anhydrous in a 50/50 ratio of polysorbate 80/dehydrated alcohol, and is ready to add to infusion solution. Each vial should be used as a single-dose and should not be used if its contents are discolored or contain particulates.*

FDA Label Image

8vail

One-VialFormulation Docetaxel Injection, USP is a cytotoxic agent that comes in a single-dose vial containing 160 mg/8 mL of docetaxel, ready to add to an infusion solution for intravenous administration. The package insert provides further instructions for use. The vial has a 12x20 mm unvarnished area, and each mL contains 20 mg of docetaxel USP and 3 mg of citric acid anhydrous in 50:50.*

FDA Label Image

Box (Box)

This text provides dosing instructions for patients being treated with docetaxel injection for breast, non-small cell lung, stomach, head and neck, and prostate cancers. Patients are advised to take their oral corticosteroid medication as prescribed by their healthcare provider. The dosing schedule is listed for each day of the treatment cycle. No further information is available.*

FDA Label Image

Carton (Carton)

FDA Label Image

Fig1 (Fig1)

FDA Label Image

Fig10 (Fig10)

FDA Label Image

Fig2 (Fig2)

FDA Label Image

Fig3 (Fig3)

FDA Label Image

Fig4 (Fig4)

The text describes the results of a survival analysis. It shows a chart with survival probabilities over time (measured in months) for a certain population. There is additional information that suggests a statistical test was performed (log-rank p-value), which tested the null hypothesis that there is no difference in survival between two or more groups. However, without further context or information, it is not possible to know what group or population is being discussed.*

FDA Label Image

Fig5 (Fig5)

FDA Label Image

Fig6 (Fig6)

FDA Label Image

Fig7 (Fig7)

FDA Label Image

Fig8 (Fig8)

FDA Label Image

Fig9 (Fig9)

FDA Label Image

Structure (Structure)

FDA Label Image

Vial (Vial)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.